Skip to main content

Table 4 Adverse events following vaccination in patients with allergic dermatitis diseases

From: Safety of inactivated SARS-CoV-2 vaccines in patients with allergic diseases

 

After first dose

After second dose

 

ADD (n = 162)

CG (n = 1545)

P value

ADD (n = 162)

CG (n = 1545)

P value

No symptoms

72 (44.4)

968 (62.7)

 < 0.001

96 (59.3)

1166 (75.5)

 < 0.001

Local reaction

55 (34.0)

309 (20.0)

 < 0.001

44 (27.2)

253 (16.4)

 < 0.001

Pain

52 (32.1)

292 (18.9)

 < 0.001

42 (25.9)

232 (15.0)

 < 0.001

Redness

2 (1.2)

8 (0.5)

0.244

1 (0.6)

11 (0.7)

0.721

Swelling

2 (1.2)

26 (1.7)

0.919

2 (1.2)

27 (1.7)

0.872

Pruritus

0

4 (0.3)

1.000

0

3 (0.2)

1.000

Malaise

0

2 (0.1)

1.000

0

1 (0.1)

1.000

Systemic reactions

51 (31.5)

354 (22.9)

0.015

30 (18.5)

172 (11.1)

0.005

Fever

2 (1.2)

28 (1.8)

0.827

0

14 (0.9)

0.448

Chills

4 (2.5)

8 (0.5)

0.020

0

5 (0.3)

1.000

Fatigue

28 (17.3)

151 (9.8)

0.003

13 (8.0)

77 (5.0)

0.099

Headache

8 (4.9)

17 (1.1)

 < 0.001

2 (1.2)

5 (0.3)

0.137

Vertigo

10 (6.2)

50 (3.2)

0.054

4 (2.5)

25 (1.6)

0.633

Somnolence

1 (0.6)

25 (1.6)

0.514

1 (0.6)

10 (0.6)

0.638

Vomiting

2 (1.2)

14 (0.9)

0.987

1 (0.6)

4 (0.3)

0.393

Diarrhea

3 (1.9)

24 (1.6)

0.967

2 (1.2)

14 (0.9)

0.987

Abdominal pain

0

6 (0.4)

1.000

0

3 (0.2)

1.000

Stuffy nose

3 (1.9)

16 (1.0)

0.583

2 (1.2)

10 (0.6)

0.721

Sore throat

6 (3.7)

27 (1.7)

0.155

4 (2.5)

16 (1.0)

0.219

Cough

1 (0.6)

14 (0.9)

0.946

3 (1.9)

9 (0.6)

0.178

Chest pain

0

1 (0.1)

1.000

0

0 (0.0)

1.000

Cardiopalmus

0

3 (0.2)

1.000

0

3 (0.2)

1.000

New or worsened

muscle pain

2 (1.2)

15 (1.0)

0.925

4 (2.5)

13 (0.8)

0.117

New or worsened joint pain

1 (0.6)

3 (0.2)

0.329

1 (0.6)

4 (0.3)

0.393

Skin rash

9 (5.6)

19 (1.2)

 < 0.001

6 (3.7)

7 (0.5)

 < 0.001